RAMM Pharma Corp. (CSE:RAMM)

Market Cap	4.18M
Revenue (ttm)	3.78M
Net Income (ttm)	-13.24M
Shares Out	119.39M
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	252,000
Average Volume	64,912
Open	0.0450
Previous Close	0.0400
Day's Range	0.0300 - 0.0450
52-Week Range	0.0100 - 0.2500
Beta	1.06
RSI	46.38
Earnings Date	Feb 27, 2026

About RAMM Pharma

RAMM Pharma Corp. engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland. It offers cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products; and pharmaceuticals, cosmetics, and nutraceutical products, as well as resells medical supplies products; and sells medical devices and consumables. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and i...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: RAMM

Financial Performance

In 2024, RAMM Pharma's revenue was 4.34 million, a decrease of -14.28% compared to the previous year's 5.07 million. Losses were -16.50 million, 113.7% more than in 2023.